Curiox BioSystems Co

Curiox BioSystems Co Acquisitions (Net)

The Acquisitions (Net) of Curiox BioSystems Co (445680.KQ) as of Oct 26, 2026 is -4.02 B KRW. In the previous year, Acquisitions (Net) was 3.11 B KRW — a change of -229.16% (lower).

Acquisitions (Net)

-4.02 BKRW

YoY

-229.16%

Last updated:

Acquisitions (Net) of Curiox BioSystems Co is 2024 -4.02 B KRW. Acquisitions (Net) of Curiox BioSystems Co was 2023 3.11 B KRW. It decreases by -229.16% lower compared to the previous year.

The Curiox BioSystems Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2021
-8.05 B KRW
Jan 1, 2022
5.57 B KRW
Jan 1, 2023
3.11 B KRW
Jan 1, 2024
-4.02 B KRW
The Curiox BioSystems Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-4.02 BKRW-229.16%
3.11 BKRW-44.21%
5.57 BKRW-169.25%
-8.05 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

Acquisitions (Net) of Curiox BioSystems Co is -4.02 B KRW in 2024.

Acquisitions (Net) of Curiox BioSystems Co changed from 3.11 B KRW to -4.02 B KRW, representing a -229.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Curiox BioSystems Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Curiox BioSystems Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Curiox BioSystems Co